Marker TherapeuticsMRKR
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 35 institutions reported holding Marker Therapeutics Inc. (MRKR) in their 13F filings, unchanged from Q1 2026. 4 opened new positions and 4 sold out. The largest holders were NEA Management Company, LLC ($2.4M), Blue Owl Capital Holdings LP ($815K) and Vanguard Capital Management LLC ($626K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Marker Therapeutics Inc.
- CUSIP
- 57055L206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $165K |
| Exits | 4 | $113K |
All 13F filers, Q1 2026 → Q2 2026: 251,350 shares bought and 184,213 shares sold, net +67,137 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 35 holders
| NEA Management Company, LLC | 0.15% | No change | 1,625,678 | $2.4M |
| Blue Owl Capital Holdings LP | 0.12% | No change | 554,250 | $815K |
| Vanguard Capital Management LLC | 0.00% | Add +9.5% | 426,169 | $626K |
| Aisling Capital Management LP | 0.10% | No change | 325,370 | $478K |
| Renaissance Technologies | 0.00% | Add +42.3% | 249,423 | $367K |
| Geode Capital Management, LLC | 0.00% | Reduce -13.1% | 139,816 | $206K |
| Osaic Holdings, Inc. | 0.00% | Add +21.0% | 112,649 | $166K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 87,269 | $128K |
| LPL Financial LLC | 0.00% | Add +0.1% | 83,147 | $122K |
| Concurrent Investment Advisors, LLC | 0.00% | New | 67,963 | $100K |
| Two Sigma Investments, LP | 0.00% | Reduce -1.3% | 60,201 | $88K |
| XTX Topco Ltd | 0.00% | Reduce -28.6% | 45,357 | $67K |
| Northern Trust Corp. | 0.00% | Add +33.1% | 34,629 | $51K |
| Citadel Advisors | 0.00% | New | 32,517 | $48K |
| State Street Corp. | 0.00% | No change | 20,948 | $31K |
| Invst, LLC | 0.00% | Reduce -37.9% | 18,000 | $26K |
| Creative Planning | 0.00% | No change | 17,312 | $25K |
| Jane Street Group, LLC | 0.00% | Reduce -53.6% | 16,832 | $25K |
| Ashton Thomas Private Wealth, LLC | 0.00% | No change | 16,400 | $24K |
| Virtu Financial LLC | 0.00% | New | 11,574 | $17K |
| Fifth Third Bancorp | 0.00% | No change | 10,000 | $15K |
| UBS Group AG | 0.00% | Reduce -74.8% | 8,150 | $12K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 2,512 | $4K |
| International Assets Investment Management, LLC | 0.00% | No change | 2,000 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -74.2% | 810 | $1K |
| Wells Fargo & Company | 0.00% | No change | 232 | $341 |
| Signaturefd, LLC | 0.00% | No change | 228 | $335 |
| SBI Securities Co., Ltd. | 0.00% | No change | 203 | $298 |
| Group One Trading LLC | 0.00% | No change | 178 | $262 |
| Hilltop National Bank | 0.00% | No change | 73 | $107 |
| Barclays PLC | 0.00% | New | 63 | $93 |
| JPMorgan Chase & Co. | 0.00% | No change | 23 | $34 |
| BNP Paribas Financial Markets | 0.00% | No change | 23 | $34 |
| Caitong International Asset Management Co., Ltd | 0.00% | Add +200.0% | 9 | $13 |
| Morgan Stanley | 0.00% | No change | 2 | $2 |
"% of holder's portfolio" is MRKR's weight in each manager's 13F, not the share of Marker Therapeutics Inc. the manager owns.